NMDA Receptor–Mediated Ca2+ Flux Attenuated by the NMDA Receptor/TRPM4 Interface Inhibitor Brophenexin
ABSTRACT Transient receptor potential melastatin‐4 (TRPM4) forms a complex with N‐methyl‐D‐aspartate receptors (NMDARs) that facilitates NMDAR‐mediated neurotoxicity. Here we used pharmacological tools to determine how TRPM4 regulates NMDAR signaling. Brophenexin, a compound that binds to TRPM4 at t...
Saved in:
| Main Authors: | Jordan Casby, Benjamin M. Gansemer, Stanley A. Thayer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Pharmacology Research & Perspectives |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/prp2.70038 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NMDA Receptors: Next therapeutic targets for Tinnitus?
by: Chenhao Che, et al.
Published: (2025-06-01) -
Inhibition of NMDA receptors and other ion channel types by membrane-associated drugs
by: Elizabeth G. Neureiter, et al.
Published: (2025-04-01) -
Neuroprotection, excitotoxicicity and nmda antagonists
by: RUBENS JOSÉ GAGLIARDI
Published: (2000-06-01) -
NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies
by: Keyi Zhang, et al.
Published: (2025-07-01) -
Intraperitoneal administration of NMDA-Subunit NR1-receptor antibodies does not improve long-term outcome in a murine MCAo-stroke model
by: Carolin Albrecht, et al.
Published: (2025-07-01)